Average Co-Inventor Count = 8.64
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (19 from 116 patents)
2. Abbott Laboratories Corporation (18 from 4,177 patents)
3. Abbvie Inc. (18 from 822 patents)
4. Abbvie S.a.r.l. (14 from 15 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
6. Karo Bio Ab (3 from 34 patents)
7. Other (2 from 832,680 patents)
8. Ligand Pharmaceuticals, Inc. (1 from 134 patents)
9. Abbvie Global Enterprises Ltd. (1 patent)
59 patents:
1. 11091507 - Methods of treating Parkinson's disease
2. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10954202 - Protein tyrosine phosphatase inhibitors and methods of use thereof
5. 10851073 - Protein tyrosine phosphatase inhibitors and methods of use thereof
6. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
9. 10730895 - Carbidopa prodrug
10. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
11. 10604515 - Heteroaryl substituted pyridines and methods of use
12. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
13. 10399940 - Substituted pyrrolidines and methods of use
14. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
15. 10174061 - Carbidopa and L-dopa prodrugs and methods of use